Skip to main content
Premium Trial:

Request an Annual Quote

Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration

NEW YORK – Saga Diagnostics said on Thursday that it has expanded its ongoing research collaboration with the University College London Cancer Institute.

The company and university began collaborating last June. As part of the new agreement, the Sweden-based firm will continue to use its SagaSafe assay (formerly IBSafe) to detect EGFR and other gene mutations, as well as perform analyses on several hundred clinical tissue samples from the Cancer Research UK-funded, UCL-sponsored TRACERx and PEACE studies.

The firm said its SagaSafe test, which is based on digital PCR and its own proprietary chemistry, has a lower limit of detection of 0.001 percent. Users can apply the assay to quantify mutations in tissue samples and ctDNA in liquid biopsy samples, such as plasma, with "unprecedented performance."

Saga expects to continue running analyses on the blood and tissue samples at its central lab in Lund.

Financial details of the agreement were not disclosed.

Last July, Saga signed an agreement with Germany-based SensID to codevelop control reagents for cancer mutation detection.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.